The Notch pathway mediates cell fate choice in many species and developmental contexts. In the Drosophila mesoderm, phenotypic differences were observed when different components of the pathway were defective. To determine if these differences reflect variations in the signaling pathway or in the persistence of wild-type maternal products, we examined muscle precursors in embryos that lacked both maternally-and zygotically-derived gene products, called holonull embryos. Most holonull neurogenic embryos have the same number and arrangement of extra muscle precursors, but in Notch holonull embryos many additional cells also become muscle precursors. Thus Notch is active in cells where its known ligands and downstream effectors are not. These results indicate that Notch acts in two pathways to determine cell fates in mesoderm: the Delta-to-Notch-to-Suppressor of Hairless-to-Enhancer of split signaling pathway previously defined, and a second pathway that acts independently.
Introduction
The Notch pathway is best known for its role in the process of lateral specification or inhibition (see Artavanis-Tsakonas et al., 1995 and Turner, 1996 for reviews) , in which cells with equivalent developmental potentials become different from one another. Lateral specification is used in a variety of developmental contexts and species, ranging from Drosophila and Caenorhabditis elegans to humans. In the Drosophila embryo, for example, equivalent cells in the ventral ectoderm compete to become neuroblasts by sending inhibitory signals to one another (see Artavanis-Tsakonas et al., 1995 for review) . The 'winners' of this signaling battle become neuroblasts; they round up, delaminate from the ectoderm and ultimately give rise to the central nervous system (CNS) of the larva. The 'inhibited' cells become epidermoblasts; they stay at the surface of the embryo and give rise to the larval epidermis. Lateral inhibition is unique from other types of cell or regional patterning in that it allows evenly spaced structures to form atop the broader patterns that give cells their diverse anteroposterior and dorsoventral identities.
Loss-of-function mutations in genes of the Notch pathway prevent cells from sending the inhibitory signal or from receiving or responding to the signal. As a consequence, all of the cells become neuroblasts at the expense of epidermoblasts (Lehmann et al., 1983) . These genes are therefore collectively called 'neurogenic genes'. However mutations in these genes lead to improper cell fate choices in all germ layers of the embryo (Lehmann et al., 1983; Corbin et al., 1991; Hartenstein et al., 1992) and in the neuroectoderm and ovary of the adult (Dietrich and Campos-Ortega, 1984; Ruohola et al., 1991) .
The Notch protein is a large transmembrane receptor that is activated by its ligand, Delta, present on the surface of neighboring cells. Upon activation, the intracellular domain of Notch (N-intra) is proteolytically clipped free of the remainder of the protein (Lecourtois and Schweisguth, 1998; Schroeter et al., 1998; Struhl and Adachi, 1998) . Nintra translocates to the nucleus and, together with Suppressor of Hairless, activates transcription of the Enhancer of split (E(spl) ) complex genes (Lecourtois and Schweisguth, 1995) . The E(spl) proteins encode basic helix-loop-helix transcription factors that repress the proneural genes of the achaete-scute complex and shunt the ectodermal cells into an epidermal fate (Heitzler et al., 1996) . The intracellular domain of Notch also appears to influence differentiation independent of Su(H) and E(spl) (Shawber et al., 1996) . However, the pathway by which it does so is not yet clear.
Genetic data indicate that mastermind (mam), big brain (bib), and neuralized (neu) are active in the Notch pathway (see e.g. de la Concha et al., 1988; Brand and CamposOrtega, 1990; Xu et al., 1990; Doherty et al., 1997) , but their biochemical functions in the pathway have not yet been elucidated.
We have studied the role of neurogenic genes in the determination of muscle precursor cells within the embryonic mesoderm. Neurogenic mutants have extra muscle precursors and a concomitant loss of an as-yet-undetermined mesodermal cell type (Corbin et al., 1991) . The similar nature of the phenotypes in the mesoderm and ectoderm suggested that neurogenic genes mediate lateral specification in both germ layers. However, small differences in the number and arrangement of extra muscle precursors in different neurogenic mutants indicates that some genes may be active where other genes are not. As these differences are not seen in the ectoderm, it is possible that the Notch pathway is different in mesoderm and ectoderm. Alternatively, at least some of the neurogenic genes are expressed maternally and the variable activity and/or persistence of these wild-type maternal products may account for the phenotypic differences.
To test the latter possibility, we compared the expression of the muscle precursor-specific protein, nau, in embryos that lack both the maternal and zygotic components of the various neurogenic genes. For convenience we call these embryos 'holonull embryos'. All holonull neurogenic mutant embryos, except Notch holonulls, have approximately the same number and arrangement of extra nauexpressing cells. These results suggest that the lateral inhibition pathway previously described for the ectoderm (where Delta activates Notch, which activates Suppressor of Hairless which activates the Enhancer of split proteins) is also active in mesoderm. This conclusion is supported by the finding that embryos doubly mutant for Delta and Su(H) are indistinguishable from those mutant for either gene alone. Surprisingly, in holonull Notch embryos about twice as many cells express nau as in the other neurogenic holonull embryos. Thus, in some mesodermal cells, Notch is active independent of its known ligands and downstream effectors. This result indicates that Notch functions in both the standard lateral inhibition pathway and in a second pathway to influence mesodermal cell fates.
Results

Different neurogenic mutants exhibit different mesodermal phenotypes
Mutations in neurogenic genes lead to the development of extra muscle precursors at the expense of one or more unknown mesodermal cell types (Corbin et al., 1991) . These cell fate changes suggest that neurogenic genes mediate lateral specification in mesoderm by the same Notchpathway that has been described to work in the ectoderm (reviewed in Artavanis-Tsakonas et al., 1995) . If so, disruptions in different parts of the pathway should give rise to similar mutant phenotypes. However, when embryos were examined with in situ probes to the muscle-specific gene nautilus (nau), we saw differences in the number and arrangement of extra muscle precursors in different neurogenic mutants (Corbin et al., 1991; Abmayr et al., 1992) . To see if these differences are maintained at the protein level, we looked at nau protein expression in neurogenic mutants with anti-nau antibodies (Fig. 1) .
Like nau mRNA, nau protein is expressed in extra cells in most of the neurogenic mutants examined ( Figs. 1 and 2 ; Table 1 ). For example, the lateral nau-expressing clusters of the second thoracic segment of wild-type embryos consist of ∼3 cells, while the same clusters in neurogenic mutant embryos consist of ∼9-13 cells (Fig. 2 , white bars; Table 2 ). In contrast to the other neurogenic mutants, Su(H) mutant embryos develop normally ( Fig. 1H ) and survive through early pupal stages (Schweisguth and Posakony, 1992) . Wild-type maternal Su(H) product placed in the eggs by their heterozygous mothers is apparently sufficient for normal embryonic and larval development (Schweisguth and Posakony, 1992) . The number of nau-expressing cells in the other neurogenic mutants is similar, but there are subtle differences in the shape of the nau-expressing cell clusters. For example, in Notch and E(spl) mutant embryos, the medial clusters expand longitudinally, forming stripes on either side of the midline (Fig. 1B,E) , while in neu and bib mutant embryos, the medial clusters expand laterally across the midline (Fig. 1D,F ). These differences could indicate that there is a differential requirement for particular neurogenic gene products in particular mesodermal cells. A second possibility, not mutually exclusive of the first, is that differences in the quantities and/or perdurance of wild-type maternal products could ameliorate the mutant phenotypes and lead to differences between them.
A novel role for Notch is revealed by the development of extra muscle precursors
To distinguish between these possibilities we used the FLP-DFS technique (Chou and Perrimon, 1992; Chou et al., 1993) to make embryos that lack both maternal and zygotic neurogenic gene products, called 'holonull embryos '. Holonull E(spl) (Lecourtois and Schweisguth, 1995) . These results were expected since zygotic Su(H) mutants develop normally through the first day of pupal development (Schweisguth and Posakony, 1992 ).
This estimate is probably low, because the depth and roundness of the clusters in the Notch holonull embryos makes discerning the inner cells difficult. In fact, dorsal views give the impression that virtually every mesodermal cell in Notch holonull embryos has adopted a nau-expressing, muscle precursor fate (Fig. 3B) . However, lateral views show that the lateral clusters are discrete (Fig. 2C) . These data clearly show that the maternal Notch product ameliorates the mesodermal phenotype of zygotic Notch mutants.
The phenotype of the Notch holonull embryos is markedly more severe than that of embryos holonull for the other neurogenic genes ( Figs. 2A and 3 , Table 2 ). More than twice as many cells express nau in each cluster of Notch holonull embryos as in the other holonull embryos (Fig. 2A) . These results show that Notch is required in more mesodermal cells than the other components of the Notch signaling pathway, including the ligand, Delta, and the downstream effectors, E(spl) and Su(H).
S59 expression in neurogenic mutants
Because the nau-expressing cell clusters in Notch holonull embryos are difficult to count, as described above, we wanted to examine a smaller, more discrete population of muscle precursors in the various neurogenic mutants. To this end we examined a subset of muscle precursors that express the S59 gene, which confers certain precursors with their identities as larval muscles 5, 18, 25, and 27 (Dohrmann et al., 1990) . S59 is initially expressed in small subsets of mesodermal cells in each hemisegment. In normal embryos at late germband extension (late stage 11), two clusters of cells express S59. 'Cluster I' first appears as a single cell that rapidly divides once, while cluster II first appears as four S59-expressing cells ( Fig.  4A ; see Dohrmann et al., 1990) .
In Delta zygotic and holonull embryos, as well as in Notch zygotic null embryos, cluster I contains ∼6 cells, while cluster II contains ∼10 cells ( Fig. 4B-D ; see also Bate et al., 1993) . As expected, Notch holonull embryos have many more S59-expressing cells per cluster than Notch zygotic or Delta zygotic or holonull embryos. These results confirm that Notch is required in more mesodermal cells than the other neurogenic genes. More significant, though, is the observation that the arrangement of the Bar graph comparing the mean number (±SD) of nau-expressing cells in the lateral cluster of the second thoracic segment of wild-type and neurogenic mutant embryos. n = 10 for all cell counts. White bars represent cell counts for mutants that lack only the zygotic component, while darkened bars represent counts for embryos that lack both the zygotic and maternal components (called holonull embryos). Cell counts for different alleles (see Table 1 ) of the same gene were combined since their values were not significantly different according to t-tests (Sokal and Rohlf, 1981) . Dl, neu, E(spl) , and bib holonull embryos have the same number of nauexpressing cells per cluster as their zygotic null counterparts. In contrast, Notch holonull embryos have more than two times as many nau-expressing cells per cluster as Notch zygotic null embryos. This result indicates that the phenotype of zygotic Notch mutants is ameliorated by wild-type maternal Notch products. Curiously, we did not recover holonull embryos for any of three different mam alleles (listed in Table 2 S59 clusters is itself altered. Clusters I and II, which were easily identified in the other neurogenic mutants (Fig. 4B-D) , are impossible to identify in Notch holonull embryos (Fig. 4E,G) . In most Notch holonull embryos (∼90%; Fig.  4E shows a representative embryo; Fig. 4F shows a higher magnification), large S59-expressing cell clusters, each composed of 40 or more cells, lie on either side of the midline. These large clusters could be the consequence of a merger between enlarged clusters I and II. Alternatively, cells unrelated to clusters I and II may have taken on an S59-expressing fate. Small clusters of 2-6 cells are also found randomly dispersed throughout the mesoderm. In the remaining Notch holonull embryos (∼10%; Fig. 4G shows a representative embryo), large, round clusters of ∼30 S59-expressing cells are found laterally together with elongated clusters of more than 100 cells near the midline that span the segment boundaries. These huge clusters are reminiscent of the neoplastic transformations caused by loss-of-function mutations in cell adhesion/tumor suppressor genes, e.g. discs large-1 (Woods and Bryant, 1991) . Although the extra muscle precursors present in zygotic Notch mutants do not arise from extra cell divisions (Corbin et al., 1991) , we cannot rule out the possibility that extra divisions do occur in the complete absence of Notch. The observation that the S59-expressing clusters are found outside their normal domains, in no apparent pattern, indicates that Notch is required to organize or to maintain the basic architecture of the mesoderm.
Serrate is not a second ligand for Notch during muscle precursor differentiation
Delta is the only known ligand for Notch that is expressed in mesoderm. A second ligand, Serrate, activates Notch during wing formation (Diaz-Benjumea and Cohen, 1995; Doherty et al., 1996) , but its role in Notch Table 1 Number of nau-expressing cells per cluster at late stage 11
Mutant
Lateral cluster of:
11.3 ± 0.6 9.3 ± 0.9 11.6 ± 1.2 N XK11 holonull 25.8 ± 1.3 24.5 ± 1.7 22.5 ± 1.3 N 55ell 10.7 ± 1.1 9.6 ± 0.7 12.1 ± 0.7 N 55ell holonull 22.8 ± 1.8 24.6 ± 2.2 22.7 ± 1.3
12.9 ± 0.5 9.5 ± 0.7 14.6 ± 0.7 bib FX1 holonull 13.1 ± 0.7 10.8 ± 0.7 14.5 ± 0.7
Dl X
13.4 ± 0.8 9.4 ± 0.7 14.5 ± 1.0 Dl X holonull 12.9 ± 1.0 12.3 ± 1.0 13.1 ± 1.7 Dl M2 11.9 ± 1.4
12.1 ± 1.0 11.6 ± 1.4 Dl M2 holonull 10.8 ± 0.6 10.1 ± 0.8 11.5 ± 1.2
11.1 ± 1.1 11.7 ± 0.8 12.3 ± 0.8 E(spl) RB251 holonull 11.3 ± 0.6 11.6 ± 0.8 11.3 ± 0.6 E(spl) R1 11.2 ± 1.1 11.6 ± 0.7 12.0 ± 0.6 E(spl) R1 holonull 11.8 ± 0.9 11.8 ± 0.6 12.5 ± 0.8
9.8 ± 0.8 10.6 ± 0.5 10.8 ± 0.6 neu IF65 9.8 ± 0.7 11.3 ± 0.6 10.7 ± 0.6 neu IF65 holonull 10.4 ± 0.7 11.6 ± 0.9 10.2 ± 0.7 neu 9L119 10.8 ± 0.9 10.7 ± 1.0 11.5 ± 0.8 neu 9L119 holonull 11.2 ± 0.9 10.9 ± 0.9 11.4 ± 0.8
Su(H) SF8
3.4 ± 0.5 3.2 ± 0.4 3.8 ± 0.6 Su(H) SF8 holonull 9.6 ± 0.9 10.3 ± 1.4 10.7 ± 1.1 Ser RX82 holonull 3.6 ± 0.7 4.3 ± 0.6 3.2 ± 0.3 Dl rev10 , Ser RX82 holonull 12.4 ± 0.9 13.7 ± 0.8 13.0 ± 0.8 Dl
M2
, Su(H) SF8 11.2 ± 0.8 11.9 ± 0.5 12.7 ± 0.6 n = 10 for all cell counts. ps, parasegment; T2, second thoracic segment; A8, eighth abdominal segment. (G) holonull embryos. This difference indicates that Notch is needed in more cells or more cell fate decisions than other genes in the pathway. The arrangement and size of the nau-expressing cell clusters are more similar between the different holonull embryos (C-G), except Notch, than between the different zygotic null embryos (compare with Fig. 1 ; see Table 1 ). However, the patterns are not identical. For example, the midline clusters in neu holonull embryos (D) sometimes expand across the midline. Nonetheless, the fact that the nau-expression pattern is very similar supports the idea that these genes work in the same pathway during muscle precursor determination. This idea is given additional support by the observation that the phenotype of double Su(H); Dl mutants (H) is no more severe than single mutants for Su(H) or Dl (E and G, respectively; see also Fig. 2A and Table 1 ). (I) The phenotype of Dl, Ser double holonull embryos is no more severe than that of Dl holonull embryos (G). (J) The nau-expression pattern of Ser holonull embryos is indistinguishable from wild-type. activation at other developmental stages and sites is not clear. During embryogenesis, Serrate is detected in the fore-and hindgut, epidermis, tracheal system, salivary glands and CNS (Thomas et al., 1991) . Although Serrate is not detected in mesoderm, it could be present at levels sufficient to stimulate Notch, but too low to detect by in situ hybridization or immunocytochemistry. Another possibility is that Serrate signaling from the ectoderm activates Notch in the mesoderm. Consistent with such a role, Serrate is expressed in ectoderm at stage 11 (Thomas et al., 1991) , just as muscle precursors become determined (Dohrmann et al., 1990) . This inductive role would be analogous to the Serrate-to-Notch signaling that goes on during wing development (Diaz-Benjumea and Cohen, 1995; Doherty et al., 1996) . Still another possibility is that Serrate may be up-regulated in the absence of Delta, such that it activates Notch ectopically. This possibility was suggested by the finding that ectopic Serrate can compensate for Delta function during embryonic neuroblast segregation (Gu et al., 1996) .
To test whether Serrate activates Notch in mesoderm, we examined nau-expressing muscle precursors in zygotic and holonull Serrate embryos and in Delta, Serrate double holonull embryos. We did not detect any mesodermal defects in either zygotic ( Fig. 2A, Table 1 ) or holonull Serrate embryos ( Fig. 2A, Fig. 3J, Table 1 ). Furthermore, the Delta, Serrate double holonull embryos have the same phenotype as the Delta holonull embryos (compare Fig. 3I with G; Fig. 2A ; Table 1 ). These results indicate that Serrate is not required for the normal development of muscle precursors and that endogenous Serrate does not compensate for the loss of Delta during muscle precursor determination. These data rule out the possibility that Serrate is a ligand for Notch in this context. Thus, in some mesodermal cell types, Notch acts independently of both Serrate and Delta, its two known ligands. The Notch holonull embryos show a more severe phenotype with extremely large clusters of S59 expressing cells. A general lack of organization of the clusters prevents the unambiguous identification of clusters I and II. In ∼90% of the embryos, the largest clusters occur laterally, as in E. F shows a higher magnification of the clusters bracketed in E. In ∼10% of the embryos, the largest clusters occur along the midline and often span segment and parasegment boundaries (G).
Delta and Suppressor of Hairless act in the same pathway to determine the same subset of muscle precursor cells
The phenotype of the holonull embryos, with the exception of the Notch holonulls, is very similar: the same number of cells become muscle precursors (Table 1 ; Fig. 2A ) and they are arranged similarly (Fig. 3) . Although some differences remain (e.g. in neu holonull embryos (Fig. 3D) , some nau-expressing clusters merge across the midline), the overall similarity suggests that the genes, including Notch, do indeed act in the lateral specification pathway previously described for the ectoderm. The severity of the Notch holonull phenotype simply indicates that Notch has a function outside of this pathway as well. To test the idea that the genes act in a common pathway, we constructed double mutants for Delta, which encodes the Notch ligand, and Su(H), which encodes an immediate downstream target of Notch activation. The Su(H); Delta double mutant embryos have the same phenotype as embryos mutant for either gene alone (compare Fig. 3H with G and E). These results support the idea that Delta and Su(H) act in the same pathway to carry out lateral specification in both mesoderm and ectoderm.
Differences in embryonic muscle precursor phenotypes cannot be accounted for by defects during oogenesis
Because neurogenic genes are required during oogenesis (Ruohola et al., 1991) , it was important to test whether the , 1995) . Delta binds to and activates Notch on neighboring cells, which allows Su(H) to activate the transcription factors within the E(spl) locus. The E(spl) factors then repress the expression or activity of 'pro-muscle' or myogenic determining genes. The myogenic determining genes can be viewed as analogous to the proneural genes of the ectoderm. Genetic data indicate that neu, mam, and bib (see Artavanis-Tsakonas et al., 1995 for review; Doherty et al., 1997 ) also fit into this pathway, but their molecular roles are not yet known. (B) Notch also appears to repress muscle precursor fates by a mechanism independent of the other neurogenic genes. In this pathway Notch is activated independently of Serrate or Delta and acts independently of its downstream effectors Su(H) and E(spl). Notch may be activated by an as yet undetermined ligand or have ligandindependent activity in some cells. It acts through unknown downstream targets to turn off the activity of myogenic determining factors. See Section 3 for further details. It is possible that the maternally-and zygotically derived proteins differentially carry out the Notch-specific and lateral inhibition functions. However, the data do not support this idea. Loss of either maternal or zygotic Notch causes a similar phenotype (J.C.R., data not shown; Jimenez and Campos-Ortega, 1982) . Furthermore, adding back extra copies of zygotic Notch to eggs that lack maternal Notch rescues most embryonic defects (Jimenez and Campos-Ortega, 1982) . These data suggest that maternal and zygotic Notch proteins are functionally identical, but that neither one alone is abundant enough to carry out all essential Notch functions. For example, maternal Notch may be essential to decide cell fates before zygotic Notch is expressed, while zygotic Notch is essential after the maternal product has been exhausted. relative over-abundance of muscle precursors in Notch holonull embryos was caused indirectly by defects in oogenesis. Both Notch and Delta are required somatically at two stages of oogenesis. The genes are first required for somatic follicle cells to delaminate and surround germ cell cysts as they leave the germarium to form a stage 1 egg chamber. Loss of Notch or Delta function at this stage prevents the egg chambers from pinching off and leads to large and swollen germaria (Ruohola et al., 1991) . Viable oocytes are not recovered. At later stages, Notch and Delta are required to prevent the over-proliferation of specialized polar follicle cells at the posterior end of the egg chamber (Ruohola et al., 1991) . Loss of Notch or Delta from the follicle cells prevents them from sending normal inductive signals to the oocyte and, as a consequence, the anteriorposterior polarity of the oocyte is disrupted (Ruohola et al., 1991) . While inducing clones in the germline for our study, we would have also induced mutant clones within the somatic follicle cells (see Section 4). Since such clones might influence oogenesis in a way that would impinge on later embryonic development, we examined the ovaries of chimeric Notch females for defects that might be attributed to Notch follicle cell clones.
The ovaries of the chimeric mothers that gave rise to the Notch germline clones were generally small and atrophied. This was expected since most of their germline stem cells carried the dominant ovo D1 mutation (linked to the Notch + gene), which prevented their development beyond the earliest stages of oogenesis (Busson et al., 1983) . A few ovarioles did develop. These were the predicted products of homozygous Notch germline stem cells that had lost the ovo D1 mutation through recombination. Within these ovarioles, most of the egg chambers were morphologically normal (Fig. 5A,B) . A few egg chambers failed to pinch off from the germarium properly and formed fused egg chambers of 32 or more cells (Fig. 5C) , reminiscent of the egg chambers of Notch ts1 females raised at the nonpermissive temperature (Ruohola et al., 1991) . Since none of the fused egg chambers could give rise to a fertile egg, they could not have contributed to the muscle precursor defects observed in the Notch holonull embryos.
All of the egg chambers that survived to stage 8 were normal with respect to anteroposterior and dorsoventral axis formation, as reflected by the distribution of bicoid, oskar, and gurken mRNAs (Fig. 5D-F) . We attribute this lack of phenotype to the fact that the Notch follicle clones were induced before the germ cells pinched off from the germarium. Thus most, if not all, egg chambers with Notch follicle cell clones had the fused egg chamber phenotype and failed to mature. To test if the kind of polarity defects observed by Ruohola et al. (1991) could, in themselves, lead to the improper determination of muscle precursors, we checked embryos from mothers homozygous for bicoid, oskar, or gurken for defects in the nau-expressing cell clusters. These embryos do show defects in the pattern of the nau-expressing cell clusters, consistent with the disruption of their axes, but they do not develop extra muscle precursor cells (data not shown). We conclude that the Notch holonull embryos were not affected by mutations in the follicle cells that surrounded them during oogenesis. Taken together, our results indicate that Notch acts independently of the other components of the lateral specification pathway during the determination of larval muscle precursors.
Discussion
We have shown that Notch acts in two separate pathways during muscle precursor development: the 'standard' lateral inhibition pathway and a second, independent pathway. The standard pathway appears to function in mesoderm much as it does in ectoderm, to prevent too many cells from becoming muscle precursors. The molecular nature of the second pathway is unknown, but it also prevents too many cells from becoming muscle precursors.
The Notch lateral inhibition pathway works in mesoderm
Three observations indicate that the lateral inhibition pathway is working in mesoderm. First, the mesodermal phenotype of neurogenic mutants is similar to the ectodermal phenotype. Second, the same subsets of mesodermal cells inappropriately become muscle precursors in all of the holonull mutants, except Notch. Third, Su(H); Delta double mutants have the same muscle precursor phenotype as either mutant alone, indicating that they act in the same pathway in mesoderm, just as they do in ectoderm. In both germ layers, lateral inhibition occurs when Delta activates Notch, which interacts with Su(H) to transcriptionally activate the E(spl) proteins (Fig. 6A) . The E(spl) proteins go on to repress the proneural genes in ectoderm (Heitzler et al., 1996) and the pro-muscle genes in mesoderm. The alternate fate choices available to the two germ layers are dictated by their developmental histories, which are determined, at least in part, by their dorsoventral and anteroposterior position in the embryo. The holonull phenotype of Notch is most likely more severe than that of the others because Notch works in both lateral inhibition and an independent, 'Notch-specific' pathway.
Notch acts independent of its known ligands and downstream effectors
In all previously examined contexts, Notch is activated or presumed to be activated by ligands present on adjacent cells. However, neither of the two known ligands, Serrate or Delta, activates the Notch-specific pathway, suggesting that a novel ligand activates Notch during the determination of particular muscle precursors. Certain genetic data have suggested that Notch may be activated by scabrous during eye development Brand and Campos-Ortega, 1990; Rabinow and Birchler, 1990 ) and the expression pattern of scabrous is consistent with it playing a role in lateral inhibition in both the embryonic mesoderm and ectoderm . However, preliminary phenotypic studies of holonull scabrous embryos suggest that removal of scabrous does not effect mesodermal patterning (J.C.R., unpublished data). Genetic data have also suggested that Notch interacts with wingless during wing development (Couso and Martinez Arias, 1994) . In the embryonic mesoderm, loss of function wingless mutations have the opposite phenotype of Notch loss-of-function mutations: many nauexpressing clusters disappear entirely and those that remain are of normal size (Ranganayakulu et al., 1996) . This finding is consistent with the idea that wingless may repress Notch. However, the observed phenotype may be the consequence of removing wingless earlier in development, as cells receive their positional identities. Loss of this early wingless function could obscure its possible later function in the Notch pathway. Experiments are currently under way to address this possibility.
While Notch may be activated by an as-yet-undiscovered ligand, it is also possible that it has some ligand-independent activity. Low levels of constitutive proteolysis could liberate the intracellular domain from the remainder of the protein, allowing it to enter the nucleus and alter gene expression. Recent data show that C-terminal portions of the intracellular domain of a modified Notch protein are cleaved and transported to the nucleus in the absence of ligand (Struhl and Adachi, 1998) . It is not clear, however, whether such cleavages occur in the normal Notch protein or, if they do, if the cleavage product has inherent signaltransducing properties. Notch could also act constitutively as a cell-adhesion molecule (Greenspan, 1990) . The tumorlike appearance of the presumptive muscle precursors in Notch holonull mutants is consistent with this idea. In this scenario, Notch would bind to adhesion molecules on adjacent cells and the resulting interactions would limit cell divisions and/or allow more specific signaling molecules to determine the cells' fates.
While our data provide the first example that Notch acts independent of its known ligands, Notch has previously been shown to act independent of its downstream effectors (de Celis et al., 1996b; Shawber et al., 1996; Wang et al., 1997) . Only a subset of the cells that require Notch and Su(H) during wing development also require E(spl) (de Celis et al., 1996a) . Similarly, all four of the cells that form the adult bristle require Notch, but only two require Su(H) (Wang et al., 1997) . Furthermore, in mouse myoblasts, portions of the intracellular Notch domain act independent of both Su(H) and E(spl) to prevent myotube formation (Shawber et al., 1996) . These examples, together with the data presented here, indicate that activated Notch influences at least two downstream processes. It remains to be shown if the mechanism by which Notch is activated dictates which downstream process is initiated.
What is the role of the Notch-specific pathway?
The one striking aspect of the Notch holonull phenotype is that a large percentage of mesodermal cells begin to differentiate as muscle precursors . This phenotype would be expected if the Notch-specific pathway limits the size or number of pro-muscle equivalence groups, much as the lateral inhibition pathway limits the number of cells that adopt the muscle precursor fate within an equivalence group (Fig. 6B) . Notch may limit equivalence groups by integrating positional signals from the dorsoventral and anteroposterior systems -or from the ectoderm -that determine or maintain the identity of pro-muscle equivalence groups. Notch could do this directly, by interacting with localized ligands, or indirectly, by maintaining the adhesive properties of cells. The observation that muscle precursor clusters span segment and parasegment boundaries in Notch holonull embryos (e.g. Fig. 4G ) is consistent with both possibilities: either the cells initially fail to read their position within the embryo and inappropriately become muscle precursors, or the presumptive muscle precursors lose their sense of place and/or adhesion at a later stage and migrate. Alternatively, the phenotype could be explained if Notch is involved in a second lateral inhibition pathway that acts amongst cells that are not included in the equivalence groups of the standard pathway. Additional experiments are needed to elucidate the mechanisms by which the Notch-specific pathway determines cell fates.
Experimental procedures
Generation of germline clones
Homozygous germ-line clones for Notch were generated using the FLiPase-Mediated, Dominant Female Sterile (FLP-DFS) technique (Chou and Perrimon, 1992) . Homozygous germ-line clones for the remaining neurogenic genes were generated using the autosomal FLP-DFS technique (Chou et al., 1993) . Both techniques take advantage of a dominant mutation in the ovo gene, ovo D1 , that renders heterozygous females sterile (Busson et al., 1983) . Recombination was induced in mid-to late third instar larvae of the genotype (FRT, ovo D1 /FRT, neurogenic mutant) by submersion in a 37°C water-bath for 2 h. This treatment induced the hs-Flipase gene that was present on another chromosome. Since oogenesis can proceed only from germ cells that have lost the ovo D1 mutation, the only viable ovarioles to emerge from this treatment come from germ cells that are homozygous for the neurogenic mutation. Because the hs-Flipase gene was active in all cells, homozygous clones were also induced in apparently random subsets of somatic cells, including the follicle cells of the ovary. After eclosion, virgins containing potential germline clones were crossed to heterozygous mutant males (i.e. neurogenic mutant/Balancer, ftz-lacZ). Holonull progeny were then identified by a lack of b-galactosidase expression. Su(H) germline clones were generated as described in Lecourtois and Schweisguth (1995) . Surprisingly, we recovered very few, if any, holonull embryos for three different mastermind alleles (J.C.R., unpublished data). Other workers have had similar experiences (B. Yedvobnick, personal communication), suggesting that the expression of mam in the germline is required for normal oogenesis.
Fly stocks
The neurogenic mutations used in this study are described in Table 1. The N XK11 FRT, ovo D1 FRT 101 ; hsFLP 38 (Struhl et al., 1993 ) stock was provided by Gary Struhl. Neurogenic mutants were crossed onto FRT-bearing chromosomes as described (Xu and Rubin, 1993) (Lecourtois and Schweisguth, 1995) .
Antibody staining of embryos
Antibody staining was carried out as described in Abmayr et al. (1992) using FAB fragments purified from their rabbit anti-nautilus antibody diluted 1:50 (generously provided by S. Abmayr) and biotinylated anti-Rb(fab′) 2 (Jackson Labs) at 1:500 dilution. After incubation with the Vector Elite ABC reagent (Vector Labs), the complex was visualized with FastDAB (Sigma). Embryos were cleared and mounted in either 1:1 Canada Balsam/methyl salicylate, or 50% glycerol, and analyzed on a Zeiss Axiophot.
In situ hybridization of ovaries and embryos
Whole-mount in situ hybridization of ovaries was carried out as described in Tautz and Pfeifle (1989) with modifications as in Cheung et al. (1992) using the Genius DNA labeling and detection kit (Boehringer Mannheim). The bcd probe corresponds to bases 761-2368 of the cDNA (Berleth et al., 1988) . The grk probe corresponds to bases 505-1630 of the genomic DNA (Neuman-Silberberg and Schupbach, 1993) . The osk probe corresponds to bases 2470 to 3432 of the cDNA (Kim-Ha et al., 1991) . All above clones were provided by Bob Cohen.
Whole-mount in situ hybridizations of embryos were carried out as described (Tautz and Pfeifle, 1989; Corbin et al., 1991) using the Genius DNA labeling and detection kit (Boehringer Mannheim). The S59 probe was a XbaI/ScaI fragment from the cDNA S59/2 (Dohrmann et al., 1990) provided by Manfred Frasch.
DAPI staining of ovaries
Ovaries were fixed as in Cheung et al. (1992) and stored in ethanol. Ovaries were rehydrated for 10 min in 1:1 PBT/ ethanol, permeabilized for 30 min in PBT, and washed for 10 min in PBS. Ovaries were stained in 0.5 mg/ml DAPI (Polysciences) in PBS for 3 h at room temperature, washed 3 × 10 min in PBS, and mounted in 80% glycerol.
Notes on cell counts
In our previous examination of zygotic neurogenic mutants by in situ hybridizations, we saw that each neurogenic mutant had a different and characteristic number of nau-expressing cells per cluster (Corbin et al., 1991) . These differences were not maintained when we looked at expression of nau protein. Instead, all of the neurogenic mutants have approximately the same number of nau-expressing cells/cluster. Furthermore, in all of the neurogenic mutants, more cells appear to express nau mRNA than express the nau protein (compare Table 1 in Corbin et al. (1991) with Table 1 from this paper). In neu IF65 mutants, for example, in situ hybridizations show that the lateral clusters of parasegment 13 contain 31 ± 8 nau-expressing cells (J.C.R., unpublished data; see also Corbin et al., 1991) , while immunocytochemistry shows that the clusters contain only 11.3 ± 0.6 nau-expressing cells (Table 1) . These results suggest that nau expression may be regulated post-transcriptionally in neurogenic mutants. The significance of this observation is unclear since nau protein is made in the same number of cells as nau mRNA in wild-type embryos.
